SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shelter Pharma informs about conference call

05 Jun 2026 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shelter Pharma has informed that the company is scheduling an H2 FY2026 Investor Conference Call on Wednesday, 10th June 2026, to discuss the Audited Financial Results of the Company for the half year and year ended 31st March 2026. The meeting may be cancelled, rescheduled or postponed due to exigencies on the part of Analysts, investors and/or Company officials. The company has enclosed a copy of the Invitation with access Link to dial-in details.

The above information is a part of company’s filings submitted to BSE.  

Shelter Pharma Share Price

29.88 0.68 (2.33%)
15-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.45
Dr. Reddys Lab 1279.25
Cipla 1381.50
Zydus Lifesciences 1087.75
Lupin 2273.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: